Macrophage Migration Inhibitory Factor for Diagnosing Endometriosis and Its Severity
NCT ID: NCT04091997
Last Updated: 2019-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2016-03-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of M1 and M2 Macrophages in Endometriotic Tissue of Women Affected by Endometriosis at Different Stages.
NCT03136978
Microbiome and Immunologic Analysis - Women With Endometriosis
NCT04159740
Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis
NCT06298617
Microbiota and Immunoassay in Women With and Without Endometriosis: a Pilot Study
NCT05433909
Endometriosis: Immunomodulation
NCT01184144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
endometriosis
laparoscopy and directed biopsy of lesions serum macrophage migration inhibitory factor ELIZA assay
serum Eliza assay
laparoscopy and biopsy of lesions in endometriotic patients and seum ELIZA assay of microphage migration inhibitory factor
control
diagnostic laparoscopy serum macrophage migration inhibitory factor ELIZA assay
serum Eliza assay
laparoscopy and biopsy of lesions in endometriotic patients and seum ELIZA assay of microphage migration inhibitory factor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
serum Eliza assay
laparoscopy and biopsy of lesions in endometriotic patients and seum ELIZA assay of microphage migration inhibitory factor
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in childbearing period,
* presenting with either gynecologic chronic pelvic pain (CPP) or infertility
* indicated and fit for diagnostic laparoscopy.
* All women must have no hormonal treatment for the last 3 months and.
Exclusion Criteria
* suspicious of gynecologic malignancy or
* active infection
19 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fayoum University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sahar MY Elbaradie
associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
fayoum UH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.